Onyx Scientific, a chemistry solutions provider to pharma and biotech companies, will continue to operate out of its Silverbriar facility (Sunderland, UK) under the Onyx Scientific trade name.
The company’s capabilities in chemistry services for medicinal, pre-clinical and Phase I/II programmes will dovetail Ipca’s capacity in supporting the scale up of programmes from the second phase of clinical trials to commercialization.
Onyx offers custom synthesis, solid state chemistry, scale up and cGMP manufacturing up to a few kilogram levels.